Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: A phase II study

Clinical Lung Cancer

Volumn 12, Issue 5, 2011, Pages 286-292

  Aydiner, Adnan ^a   Sen, Fatma ^a   Saglam, Esra Kaytan ^a   Oral, Ethem Nezih ^a   Eralp, Yesim ^a   Tas, Faruk ^a   Toker, Alper ^b   Dilege, Sukru ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cisplatin; Concomitant chemoradiotherapy; Docetaxel; Induction; Locally advanced disease; Non small cell lung cancer

Indexed keywords

CISPLATIN; DOCETAXEL;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DIARRHEA; DRUG RESPONSE; DRUG TOLERABILITY; ESOPHAGITIS; FEASIBILITY STUDY; FEMALE; HUMAN; LEUKOPENIA; LOBECTOMY; LUNG COMPLICATION; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; RADIATION DOSE; SKIN TOXICITY; THORACOTOMY; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDUCTION CHEMOTHERAPY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; SURVIVAL RATE; TAXOIDS; TREATMENT OUTCOME;

EID: 80052479472     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2011.03.030     Document Type: Article

References (25)

1. D.G. Pfister, D.H. Johnson, C.G. Azzoli American Society of Clinical Oncology American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003 J Clin Oncol 22 2004 330 353 (Pubitemid 41095099)
2. W. Sause, P. Kolesar, and S. Taylor IV Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group Chest 117 2000 358 364 (Pubitemid 30111583)
3. E.E. Vokes, J. Crawford, and J. Bogart Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer Clin Cancer Res 11 2005 5045 5050
4. K. Furuse, M. Fukuoka, and M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699 (Pubitemid 29415225)
5. W. Eberhardt, H. Wilke, and G. Stamatis Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial J Clin Oncol 16 1998 622 634 (Pubitemid 28135609)
6. A. Marra, W. Eberhardt, and C. Pöttgen Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour Eur Respir J 29 2007 117 126
7. H.A. Tawfik, Ael-H. Taha, and G.A. Attia Induction docetaxel and cisplatin followed by weekly docetaxel and cisplatin with concurrent radiotherapy in locally advanced stage III non small cell lung cancer (LA-NSCLC)a phase II study J Egypt Natl Canc Inst 19 2007 15 20
8. P. Garrido, R. Rosell, and B. Massutí Predictors of long-term survival in patients with lung cancer included in the randomized Spanish Lung Cancer Group 0008 phase II trial using concomitant chemoradiation with docetaxel and carboplatin plus induction or consolidation chemotherapy Clin Lung Cancer 10 2009 180 186
9. L. Milas Docetaxel/radiation combinations: rationale and preclinical findings Clin Lung Cancer 3 2002 29 36
10. G.V. Scagliotti, and A.T. Turrisi 3rd Docetaxel-based combined-modality chemoradiotherapy for locally advanced non-small cell lung cancer Oncology 8 2003 361 374 (Pubitemid 36929721)
11. E.S. Kim, and F.R. Khuri Docetaxel and radiation as combined-modality therapy Oncology 16 2002 97 105
12. G.V. Scagliotti, A. Szczesna, and R. Ramlau Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer Br J Cancer 94 2006 1375 1382 (Pubitemid 43772269)
13. D.C. Betticher, S.F. Hsu Schmitz, and M. Totsch Mediastinal lymph node clearance after docetaxelcisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial J Clin Oncol 21 2003 1752 1759 (Pubitemid 46638588)
14. E.E. Vokes, J.E. Herndon 2nd, and M.J. Kelley Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B J Clin Oncol 25 2007 1698 1704 (Pubitemid 46797950)
15. E.E. Vokes, J.E. Herndon 2nd, and J. Crawford Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431 J Clin Oncol 20 2002 4191 4198 (Pubitemid 35191021)
16. M. Kocak, A. Ozkan, and A. Mayadagli Induction chemotherapy and chemoradiation therapy for inoperable locally advanced non-small-cell lung cancer: a single-institution review of two different regimens Clin Lung Cancer 10 2009 124 129
17. B. Biesma, C. Manegold, and H.J. Smit Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984) Eur J Cancer 42 2006 1399 1406 (Pubitemid 43903154)
18. D.R. Gandara, K. Chansky, and K.S. Albain Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504 J Clin Oncol 21 2003 2004 2010 (Pubitemid 46606390)
19. N. Hanna, M. Neubauer, and C. Yiannoutsos Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology J Clin Oncol 26 2008 5755 5760
20. C.P. Belani, H. Choy, and P. Bonomi Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol J Clin Oncol 23 2005 5883 5891
21. S. Kusumoto, T. Hirose, and M. Fukayama Induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer Oncol Rep 22 2009 1157 1162
22. H. Yokomise, M. Gotoh, and T. Okamoto Induction chemoradiotherapy (carboplatin-taxane and concurrent 50-Gy radiation) for bulky cN2, N3 non-small cell lung cancer J Thorac Cardiovasc Surg 133 2007 1179 1185 (Pubitemid 46635502)
23. A.O. Kaya, S. Buyukberber, and M. Benekli Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer Med Oncol 27 2010 152 157
24. R. Blanco, J. Solé, and J. Montesinos Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: final results of a phase II study Lung Cancer 62 2008 62 71
25. A. Vergnengre, C. Daniel, and H. Léna Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer A phase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC) Lung Cancer 47 2005 395 404 (Pubitemid 40248744)